Effects of genotypic differences in CYP2C19 status on cure rates for Helicobacter pylori infection by dual therapy with rabeprazole plus amoxicillin

2001 ◽  
Vol 11 (4) ◽  
pp. 341-348 ◽  
Author(s):  
Takahisa Furuta ◽  
Naohito Shirai ◽  
Misako Takashima ◽  
Fang Xiao ◽  
Hiroyuki Hanai ◽  
...  
Keyword(s):  
Helicobacter Pylori ◽  
Dual Therapy ◽  
Helicobacter Pylori Infection ◽  
Genotypic Differences ◽  
Cure Rates

Cytochrome P450 2C19 (CYP2C19) genotype status is not associated with cure rates of dual therapy with rabeprazole and amoxicillin for Helicobacter pylori

2001 ◽  
Vol 120 (5) ◽  
pp. A587 ◽  
Author(s):  
Masakatsu Uchihara ◽  
Namiki Izumi ◽  
Osamu Noguchi ◽  
Yasuhiro Asahina ◽  
Nobuhiko Kanazawa ◽  
...  
Keyword(s):  
Helicobacter Pylori ◽  
Cytochrome P450 ◽  
Dual Therapy ◽  
Cyp2c19 Genotype ◽  
Cytochrome P450 2C19 ◽  
Cure Rates

770 High Cumulative Eradication Rate in the First-Line and Rescue Therapies for Helicobacter pylori Infection by Repeated Optimized High Dose Dual Therapy

2015 ◽  
Vol 148 (4) ◽  
pp. S-149
Author(s):  
Jyh-Chin Yang ◽  
Chun-Jung Lin ◽  
Jin-De Chen ◽  
Hong-Long Wang ◽  
John Y. Kao ◽  
...  
Keyword(s):  
Helicobacter Pylori ◽  
Eradication Rate ◽  
Dual Therapy ◽  
Helicobacter Pylori Infection ◽  
High Dose ◽  
First Line

Comparison of dual therapy of rabeprazole plus amoxicillin and triple therapy for cure of Helicobacter pylori infection

2001 ◽  
Vol 120 (5) ◽  
pp. A584-A585 ◽  
Author(s):  
T KAWAI ◽  
K OGUMA ◽  
T KUDOU ◽  
S OGIHARA ◽  
H OONO ◽  
...  
Keyword(s):  
Helicobacter Pylori ◽  
Triple Therapy ◽  
Dual Therapy ◽  
Helicobacter Pylori Infection
Sign in / Sign up

Export Citation Format

Share Document